Since 2015, Novus Acquisition & Development Corporation (NDEV), doing business as Novus Cannabis MedPlan®, has been a pioneering health insurance carrier that integrates THC and CBD cannabis into health plans for both medical and recreational cannabis consumers. With a national network of agents, brokers, and dispensaries, NDEV generates revenue through insurance premiums and provides policyholders access to cannabis and traditional medications through its prescription and cannabis distribution online platform. NDEV’s sustainability is based on its receivable-based business model and has attracted interest from major carriers and InsurTech platforms for plan integration.
Potential investors should consult with their investment professional regarding Novus trading below its intrinsic value. This situation can be evaluated using the Benefit Monetization Ratio, which supports Novus’s long-term vision, sustainable business model, and potential for future growth.
| Authorized Shares: | 200 million | |
| Outstanding Shares: | 126,803,624 | |
| Float: | 30,948,730 | |
| Par Value: | $0.001 | |
| Restricted Shares: | 86,989,251 | |
| Quote: | Click Here |
| Filings: | Click Here |
| Pitch Deck: | Click Here |
| Investment Highlights Video: | Click Here |
Footnotes:
The platform targeted medical users, unregistered consumers from the illicit market, and recreational users.
Novus is not impacted by the SAFE Banking Act or the process of rescheduling cannabis. As a non-plant-touching company, we encounter fewer legal and regulatory challenges. Insurance providers operate on a state-by-state basis, and since federal cannabis laws do not apply directly to us, we are able to operate across state and national borders with fewer restrictions.
